Goldentree Asset Management LP's Form 4 filing
Keenova Therapeutics plc (MNKTQ) · filed Aug 6, 2025
- Accession no.
- 0001641172-25-022471
- Filed
- Aug 6, 2025, 7:45 PM ET
- Trade date
- Aug 4-6, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $3.24M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goldentree Asset Management LPCIK 0001278951 | 10% Owner |
| Tananbaum Steven A.CIK 0001435626 | 10% Owner |
| GoldenTree Asset Management LLCCIK 0001435627 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2025 | Ordinary Shares | PPurchaseAcquired | +30,000 | $87.25 | +$2,617,500 | 7,939,476 | Indirect | |
| Aug 6, 2025 | Ordinary Shares | PPurchaseAcquired | +6,700 | $92.50 | +$619,750 | 7,946,176 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.